Keyphrases
Sickle Cell Disease
100%
Pediatric
53%
Chronic Granulomatous Disease
47%
Neutrophils
43%
NADPH Oxidase
40%
Hematopoietic Stem Cells
39%
GATA4
37%
Graft-versus-host Disease (GvHD)
37%
Tumor
36%
Hematopoietic Cell Transplantation
35%
Gp91phox
34%
Transcription Factor
31%
Survivors
31%
Von Willebrand Factor
30%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
28%
X-linked Chronic Granulomatous Disease (X-CGD)
28%
Platelets
27%
Pediatric Patients
27%
Acute Myeloid Leukemia
25%
Neurofibromatosis Type 1 (NF-1)
25%
Von Willebrand Disease
25%
Glioblastoma
23%
Ubiquitin
23%
Asialoglycoprotein Receptor (ASGPR)
23%
Confidence Interval
22%
Chemotherapy
22%
Older Adults
22%
Low-density Lipoprotein Receptor
22%
Medulloblastoma
22%
Sickle Cell Anemia
21%
Transplantation
20%
Hematopoietic Stem Cell Transplantation
19%
Neurofibromatosis Type I
19%
Cell Surface
17%
Brain Tumor
17%
Overall Survival
17%
Pediatric Oncology
17%
Oxidase
17%
Sex Differences
17%
Mouse Model
17%
Leukemia
16%
High Risk
16%
Rac2
16%
Macrophages
15%
Stem Cell Transplantation
15%
Phagocytes
15%
Clinical Trials
15%
Hepatoma Cells
15%
Late Effects
15%
125I
15%
Endocytosis
15%
Glioma
14%
GATA6
14%
P22phox
14%
Gene Expression
14%
Odds Ratio
14%
Reduced-intensity Conditioning
14%
In Cancer
14%
Central Nervous System
14%
Oncology
14%
Hemophilia
14%
Superoxide Production
14%
Adrenocortical
13%
Ubiquitin System
13%
Marrow Transplantation
13%
Inflammation
13%
Transfusion
13%
Thrombosis
12%
HepG2 Cells
12%
United States
12%
Receptor-mediated Endocytosis
12%
Superoxide
12%
Gene Therapy
12%
Lipoprotein Receptor-related Protein
12%
Unrelated Donor
12%
Bone Marrow
12%
Myelodysplastic Syndrome
12%
B Cells
12%
Tumor Cells
12%
Gene Transfer
12%
Survivorship
12%
Risk Factors
12%
Tumorigenesis
12%
Nicotinamide Adenine Dinucleotide Phosphate Oxidase
11%
C-X-C Chemokine Receptor Type 4 (CXCR4)
11%
Children's Oncology Group
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Complementary DNA (cDNA)
11%
Flavocytochrome
11%
Apoptosis
11%
Hydroxyurea
11%
NADPH Oxidase Activity
11%
Severe Combined Immunodeficiency
11%
Engraftment
11%
Cytochrome b
10%
P47phox
10%
Radiation Therapy
10%
Childhood Cancer Survivor Study
10%
Childhood Cancer Survivors
10%
X-linked
10%
Medicine and Dentistry
Sickle-Cell Disease
92%
Pediatrics
82%
Hematopoietic Cell
63%
Diseases
58%
Neoplasm
50%
Malignant Neoplasm
49%
Transplantation
43%
Adolescence
38%
Cell Transplantation
36%
Childhood Cancer
32%
Oncology
28%
Ganglioglioma
26%
Hematopoietic Stem Cell Transplantation
24%
Platelet
23%
Von Willebrand Factor
22%
Pediatrics Patient
21%
Apoplexy
20%
Leukemia
19%
Neurofibromatosis Type I
19%
Von Willebrand Disease
19%
Quality of Life
18%
Bleeding
17%
Clinician
17%
Medulloblastoma
17%
Acute Myeloid Leukemia
16%
Transcription Factor GATA 4
16%
Overall Survival
16%
Thrombosis
15%
Graft Versus Host Reaction
15%
Clinical Trial
15%
Disease
14%
Radiation Therapy
14%
Cancer
13%
Late Effect
13%
Acute Lymphoblastic Leukemia
13%
Myelodysplastic Syndrome
12%
Intracranial Tumor
12%
Chronic Granulomatous Disease
12%
Surgery
11%
Pediatric Cancer
11%
Infection
11%
Glioblastoma
11%
In Vitro
11%
Odds Ratio
10%
Prevalence
10%
Receptor
10%
Conditioning
10%
Cell Therapy
10%
Diagnosis
10%
T Cell
10%
Central Nervous System
10%
Engraftment
10%
Stem Cell Therapy
9%
Oxidoreductase
9%
Neutrophil
9%
Hydroxyurea
9%
Brain Infarction
9%
Sex Difference
9%
Magnetic Resonance Imaging
9%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
9%
Sickle Cell
9%
B Cell
9%
Haemophilia A
9%
Cell Function
9%
Event Free Survival
8%
Blood Stasis
8%
Thrombocytopenia
8%
Reduced Intensity Conditioning
8%
Patient with Sickle Cell Disease
8%
Hematopoiesis
8%
Blood Transfusion
8%
Germinoma
7%
Infarction
7%
Recurrent Disease
7%
Systematic Review
7%
Transcription Factor GATA 6
7%
Acute Leukemia
7%
Immune Deficiency
7%
Posttransplant Lymphoproliferative Disease
7%
Medicine
7%
Pediatric Brain Tumor
7%
Methotrexate
7%
Wilms' Tumor
7%
Cancer Therapy
6%
Vascular Anomaly
6%
Allograft
6%
Lung
6%
Gene Expression
6%
Central Nervous System Tumor
6%
Tumor Progression
6%
Disease Predisposition
6%
Granulocyte Colony Stimulating Factor
6%
Plexiform Neurofibroma
6%
Cord Blood
6%
Stem Cell Transplant
6%
Toddlers
6%
Hemodynamic
6%
Stem Cell
6%
Biological Marker
6%
Severe Combined Immunodeficiency
6%
Biochemistry, Genetics and Molecular Biology
Hematopoietic Cell
44%
Ubiquitin
44%
NAD(P)H Oxidase
43%
Genetics
34%
Myeloid
31%
Oxidoreductase
31%
Oxidase
29%
LDL Receptor
25%
GATA4
25%
Platelet
23%
Phagocyte
23%
Lipoprotein Receptor-Related Protein
19%
Enzyme
19%
Von Willebrand Factor
17%
Endocytosis
17%
Carcinogenesis
17%
Gene Expression
16%
Transcription Factors
15%
Wild Type
15%
N-Terminus
15%
Promoter Region
15%
Proteasome
14%
Sex Difference
14%
Ubiquitin-Conjugating Enzyme
13%
Stem Cell
11%
C-Terminus
11%
Genomics
11%
Blood Plasma
11%
Conditioning
11%
Cell Transplantation
11%
Gene Therapy
11%
Germ Cell
11%
Programmed Cell Death
10%
Iodine-125
10%
Messenger RNA
10%
B Cell
10%
RNA
10%
Ubiquitination
10%
Von Willebrand Disease
10%
Cell Function
10%
Precursor
10%
Asialoglycoprotein Receptor
10%
Maturation
10%
Phosphotransferase
10%
Kinase
10%
Cyclic Adenosine Monophosphate
9%
Metabolic Pathway
9%
Amino Acids
9%
Germline
9%
P22phox
9%
Overall Survival
9%
Plasminogen Activator
9%
Transcription
9%
Hematopoiesis
9%
Tumor Suppressor Protein
8%
Subcellular Localization
8%
Nicotinamide Adenine Dinucleotide Phosphate
8%
P53
8%
Tissue Plasminogen Activator
8%
Epigenetics
8%
Cancer Cell
8%
Macrophage
8%
Mouse Model
8%
Respiratory Burst
8%
Allele
7%
Clinical Trial
7%
Progenitor Cell
7%
GATA6
7%
Tissue Factor Pathway Inhibitor
7%
MyoD
7%
Tumor Progression
7%
Haemophilia A
7%
RNA Sequence
7%
Cell Cycle
7%
Cell Proliferation
6%
Sonic Hedgehog
6%
Adolescence
6%
Factor VIII
6%
Adenosine Triphosphate
6%
Dyskeratosis Congenita
6%
Zebra Fish
6%
Methylation
6%
Cell Membrane
6%
Cytochrome B
6%
Protein Biosynthesis
6%
Host
6%
Ligand Binding
6%
Enhancer Region
6%
Hematopoietic Stem Cell Transplantation
6%
Cytochrome
6%
Immunity
6%
Anabolism
6%
Binding Protein
6%
Isoform
6%
Actin
6%
DNA Methylation
6%
Chemotaxis
5%
Plasminogen Activator Inhibitor-1
5%
Lysine
5%
Cell Survival
5%